Dupixent

Client: Sanofi-Regeneron
Agency: Havas Health Plus
Role: Senior Art Director

Challenge:
Dupixent, a leading biologic treatment for chronic inflammatory diseases such as eczema and asthma, required a broad range of digital and print assets to support ongoing engagement with patients, healthcare professionals (HCPs), and stakeholders. Additionally, with the 2024 tradeshow update and the launch of the new Chronic Spontaneous Urticaria (CSU) indication, the brand needed compelling promotional materials, patient journeys, and launch assets to drive awareness and adoption.

• Developed digital and print assets including emails, ad banners, social media posts, sales collateral and the 2024 AAP tradeshow booth

• Created a comprehensive patient journey covering all four age groups within Dupixent’s atopic dermatitis (AD) indication, delivering this in both digital and print formats for maximum accessibility.

• Supported the launch of the CSU indication by developing launch video and graphics.